Govt places new purchase order with SII for 10 crore doses of Covishield vaccine

By: |
March 16, 2021 8:49 PM

The cost of the 10 crore doses would be borne by the health ministry under the budgetary allocation for the purpose.

covishieldThe expenditure for the earlier orders of the vaccines was funded through the PM Cares Fund

The Centre has placed a new purchase order with the Serum Institute of India (SII) for the supply of 10 crore doses of the Oxford-AstraZeneca COVID-19 vaccine, Covishield, each costing Rs 157.50, including GST, according to official sources.

The HLL Lifecare Limited, a public sector undertaking, has issued the supply order on behalf of the Union health ministry on March 12 in the name of Prakash Kumar Singh, Director, Government and Regulatory Affairs at the Pune-based SII.

The cost of the 10 crore doses would be borne by the health ministry under the budgetary allocation for the purpose.

The expenditure for the earlier orders of the vaccines was funded through the PM Cares Fund, the sources said.

India has approved two vaccines against COVID-19 — Covishield, manufactured by the SII, and the indigenously-developed Covaxin of Bharat Biotech—for restricted emergency use in the country.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1New vaccine orders from Centre will cost Rs 400 per dose: Serum Institute
2COVID-19 vaccination: Vaccinate banking staff on priority basis, Finance Ministry tells states
3COVID-19: CSIR lab develops technology to meet oxygen demand, minimise storage risks